NCT00586846View on ClinicalTrials.gov

Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Osteosarcoma
Interventions
DRUG

Cisplatin

Cisplatin 120 mg/m\^2

DRUG

Doxorubicin

75mg/m\^2

DRUG

Methotrexate

Methotrexate 12g/m\^2

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00586846 - Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma | Biotech Hunter | Biotech Hunter